Life Sciences
Home >> Views >> Life Sciences
Shanxi Guangyuyuan TCM Pharma in order to concentrate on TCM business is about to sell its non-core business
Source£ºCCMR   Data£º2013-12-5

400-year history TCM maker Shanxi Guangyuyuan is to sell its non-core business Anhui Dongshen Pharmaceutical Co. and two pharmaceutical factories to Guangdong HengCheng Pharmaceutical company with RMB 145 million.

The intended sold companies primarily major in fertiliser and crude drug R&D and sales. After stripping of these businesses, Guangyuyuan could pay more attention on its core business in TCM R&D and manufacturing. 

Related Hot
Copyright © 2012-2020  CCMR | China Ceidea Market Research Co., LTD  Inc. All rights reserved.
Add£ºRoom 406 Huide Building No 102 Hao Xian Road Yuexiu District Guangzhou Tel£º+86-020-28931413 +86 13503051005 
 BINWEB